This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
AL-Dulaimi M, Algburi A, Abdelhameed A, Mazanko MS, Rudoy DV, Ermakov AM, Chikindas ML. Antimicrobial and anti-biofilm activity of polymyxin E alone and in combination with probiotic strains of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 against clinical isolates of selected Acinetobacter spp.: a preliminary study. Pathogens. 2021 Dec;10(12):1574. https://doi.org/10.3390/pathogens10121574AL-DulaimiMAlgburiAAbdelhameedAMazankoMSRudoyDVErmakovAMChikindasML. Antimicrobial and anti-biofilm activity of polymyxin E alone and in combination with probiotic strains of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 against clinical isolates of selected Acinetobacter spp.: a preliminary study. 2021Dec; 10(12):1574. https://doi.org/10.3390/pathogens10121574Search in Google Scholar
Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, Korennykh A, Donia MS. The human microbiome encodes resistance to the antidiabetic drug acarbose. Nature. 2021 Dec; 600(7887): 110–115. https://doi.org/10.1038/s41586-021-04091-0BalaichJEstrellaMWuGJeffreyPDBiswasAZhaoLKorennykhADoniaMS. The human microbiome encodes resistance to the antidiabetic drug acarbose. 2021Dec; 600(7887): 110–115. https://doi.org/10.1038/s41586-021-04091-0Search in Google Scholar
Bock PM, Telo GH, Ramalho R, Sbaraini M, Leivas G, Martins AF, Schaan BD. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. Diabetologia. 2021 Jan;64(1):26–41. https://doi.org/10.1007/s00125-020-05295-1BockPMTeloGHRamalhoRSbarainiMLeivasGMartinsAFSchaanBD. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. 2021Jan; 64(1):26–41. https://doi.org/10.1007/s00125-020-05295-1Search in Google Scholar
Buse JB, DeFronzo RA, Rosenstock J, Kim T, Burns C, Skare S, Baron A, Fineman M. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care. 2016 Feb;39(2):198–205. https://doi.org/10.2337/dc15-0488BuseJBDeFronzoRARosenstockJKimTBurnsCSkareSBaronAFinemanM. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. 2016Feb; 39(2):198–205. https://doi.org/10.2337/dc15-0488Search in Google Scholar
Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019 May;15(5):261–273. https://doi.org/10.1038/s41574-019-0156-zCanforaEEMeexRCRVenemaKBlaakEE. Gut microbial metabolites in obesity, NAFLD and T2DM. 2019May; 15(5):261–273. https://doi.org/10.1038/s41574-019-0156-zSearch in Google Scholar
de Cossío LF, Fourrier C, Sauvant J, Everard A, Capuron L, Cani PD, Layé S, Castanon N. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome. Brain Behav Immun. 2017 Aug;64:33–49. https://doi.org/10.1016/j.bbi.2016.12.022de CossíoLFFourrierCSauvantJEverardACapuronLCaniPDLayéSCastanonN. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome. 2017Aug;64:33–49. https://doi.org/10.1016/j.bbi.2016.12.022Search in Google Scholar
Dey S, Blanch-Asensio M, Balaji Kuttae S, Sankaran S. Novel genetic modules encoding high-level antibiotic-free protein expression in probiotic lactobacilli. Microb Biotechnol. 2023 Feb; 1751–7915.14228. https://doi.org/10.1111/1751-7915.14228DeySBlanch-AsensioMBalaji KuttaeSSankaranS. Novel genetic modules encoding high-level antibiotic-free protein expression in probiotic lactobacilli. 2023Feb; 1751–7915.14228. https://doi.org/10.1111/1751-7915.14228Search in Google Scholar
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013 May;110(22):9066–9071. https://doi.org/10.1073/pnas.1219451110EverardABelzerCGeurtsLOuwerkerkJPDruartCBindelsLBGuiotYDerrienMMuccioliGGDelzenneNMCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. 2013May; 110(22):9066–9071. https://doi.org/10.1073/pnas.1219451110Search in Google Scholar
Fernandez MA, Marette A. Potential health benefits of combining yogurt and fruits based on their probiotic and prebiotic properties. Adv Nutr. 2017 Jan;8(1):155S–164S. https://doi.org/10.3945/an.115.011114FernandezMAMaretteA. Potential health benefits of combining yogurt and fruits based on their probiotic and prebiotic properties. 2017Jan; 8(1):155S–164S. https://doi.org/10.3945/an.115.011114Search in Google Scholar
Gao M, Jebb SA, Aveyard P, Ambrosini GL, Perez-Cornago A, Papier K, Carter J, Piernas C. Associations between dietary patterns and incident type 2 diabetes: prospective cohort study of 120,343 UK Biobank participants. Diabetes Care. 2022 Jun;45(6):1315–1325. https://doi.org/10.2337/dc21-2258GaoMJebbSAAveyardPAmbrosiniGLPerez-CornagoAPapierKCarterJPiernasC. Associations between dietary patterns and incident type 2 diabetes: prospective cohort study of 120,343 UK Biobank participants. 2022Jun; 45(6):1315–1325. https://doi.org/10.2337/dc21-2258Search in Google Scholar
Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):491–502. https://doi.org/10.1038/nrgastro.2017.75GibsonGRHutkinsRSandersMEPrescottSLReimerRASalminenSJScottKStantonCSwansonKSCaniPDExpert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. 2017Aug; 14(8):491–502. https://doi.org/10.1038/nrgastro.2017.75Search in Google Scholar
Gordon B, Ridinger S, Krick R, Grosvenor L, Charron R. Fruit and vegetable prescription program for diabetes control among community health centers in Rural Idaho and Oregon. Am J Public Health. 2022 Jul;112(7):975–979. https://doi.org/10.2105/AJPH.2022.306853GordonBRidingerSKrickRGrosvenorLCharronR. Fruit and vegetable prescription program for diabetes control among community health centers in Rural Idaho and Oregon. 2022Jul; 112(7):975–979. https://doi.org/10.2105/AJPH.2022.306853Search in Google Scholar
Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019 Apr;4(4):CD004827. https://doi.org/10.1002/14651858.CD004827.pub5GuoQGoldenbergJZHumphreyCEl DibRJohnstonBC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. 2019Apr; 4(4):CD004827. https://doi.org/10.1002/14651858.CD004827.pub5Search in Google Scholar
Healey G, Brough L, Butts C, Murphy R, Whelan K, Coad J. Influence of habitual dietary fibre intake on the responsiveness of the gut microbiota to a prebiotic: protocol for a randomised, double-blind, placebo-controlled, cross-over, single-centre study. BMJ Open. 2016 Sep;6(9):e012504. https://doi.org/10.1136/bmjopen-2016-012504HealeyGBroughLButtsCMurphyRWhelanKCoadJ. Influence of habitual dietary fibre intake on the responsiveness of the gut microbiota to a prebiotic: protocol for a randomised, double-blind, placebo-controlled, cross-over, single-centre study. 2016Sep; 6(9):e012504. https://doi.org/10.1136/bmjopen-2016-012504Search in Google Scholar
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506–514. https://doi.org/10.1038/nrgastro.2014.66HillCGuarnerFReidGGibsonGRMerensteinDJPotBMorelliLCananiRBFlintHJSalminenSThe International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. 2014Aug; 11(8):506–514. https://doi.org/10.1038/nrgastro.2014.66Search in Google Scholar
Holman N, Young B, Gadsby R. Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. Diabet Med. 2015 Sep;32(9):1119–1120. https://doi.org/10.1111/dme.12791HolmanNYoungBGadsbyR. Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. 2015Sep; 32(9):1119–1120. https://doi.org/10.1111/dme.12791Search in Google Scholar
Holt S, Carter DC, Tothill P, Heading RC, Prescott LF. Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet. 1979 Mar;313(8117):636–639. https://doi.org/10.1016/S0140-6736(79)91079-1HoltSCarterDCTothillPHeadingRCPrescottLF. Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. 1979Mar; 313(8117):636–639. https://doi.org/10.1016/S0140-6736(79)91079-1Search in Google Scholar
Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M, Nagatake T, Konishi K, Ohno H, Tanisawa K, et al. Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota. Nat Commun. 2022 Aug;13(1):4477. https://doi.org/10.1038/s41467-022-32015-7HosomiKSaitoMParkJMurakamiHShibataNAndoMNagatakeTKonishiKOhnoHTanisawaKOral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota. 2022Aug; 13(1):4477. https://doi.org/10.1038/s41467-022-32015-7Search in Google Scholar
Kanazawa A, Aida M, Yoshida Y, Kaga H, Katahira T, Suzuki L, Tamaki S, Sato J, Goto H, Azuma K, et al. Effects of synbiotic supplementation on chronic inflammation and the gut microbiota in obese patients with type 2 diabetes mellitus: A randomized controlled study. Nutrients. 2021 Feb;13(2):558. https://doi.org/10.3390/nu13020558KanazawaAAidaMYoshidaYKagaHKatahiraTSuzukiLTamakiSSatoJGotoHAzumaKEffects of synbiotic supplementation on chronic inflammation and the gut microbiota in obese patients with type 2 diabetes mellitus: A randomized controlled study. 2021Feb; 13(2):558. https://doi.org/10.3390/nu13020558Search in Google Scholar
Kesika P, Sivamaruthi BS, Chaiyasut C. Do probiotics improve the health status of individuals with diabetes mellitus? A review on outcomes of clinical trials. BioMed Res Int. 2019 Dec;2019:1–11. https://doi.org/10.1155/2019/1531567KesikaPSivamaruthiBSChaiyasutC. Do probiotics improve the health status of individuals with diabetes mellitus? A review on outcomes of clinical trials. 2019Dec;2019:1–11. https://doi.org/10.1155/2019/1531567Search in Google Scholar
Kocsis T, Molnár B, Németh D, Hegyi P, Szakács Z, Bálint A, Garami A, Soós A, Márta K, Solymár M. Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials. Sci Rep. 2020 Jul;10(1):11787. https://doi.org/10.1038/s41598-020-68440-1KocsisTMolnárBNémethDHegyiPSzakácsZBálintAGaramiASoósAMártaKSolymárM. Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials. 2020Jul; 10(1):11787. https://doi.org/10.1038/s41598-020-68440-1Search in Google Scholar
Kumar V, Sinha AK, Makkar HPS, de Boeck G, Becker K. Dietary roles of non-starch polysaccharides in human nutrition: a review. Crit Rev Food Sci Nutr. 2012 Oct;52(10):899–935. https://doi.org/10.1080/10408398.2010.512671KumarVSinhaAKMakkarHPSde BoeckGBeckerK. Dietary roles of non-starch polysaccharides in human nutrition: a review. 2012Oct; 52(10):899–935. https://doi.org/10.1080/10408398.2010.512671Search in Google Scholar
Lee SH, Moore LV, Park S, Harris DM, Blanck HM. Adults meeting fruit and vegetable intake recommendations – United States, 2019. MMWR Morb Mortal Wkly Rep. 2022 Jan;71(1):1–9. https://doi.org/10.15585/mmwr.mm7101a1LeeSHMooreLVParkSHarrisDMBlanckHM. Adults meeting fruit and vegetable intake recommendations – United States, 2019. 2022Jan; 71(1):1–9. https://doi.org/10.15585/mmwr.mm7101a1Search in Google Scholar
Li Q, Hu J, Nie Q, Chang X, Fang Q, Xie J, Li H, Nie S. Hypoglycemic mechanism of polysaccharide from Cyclocarya paliurus leaves in type 2 diabetic rats by gut microbiota and host metabolism alteration. Sci China Life Sci. 2021 Jan;64(1):117–132. https://doi.org/10.1007/s11427-019-1647-6LiQHuJNieQChangXFangQXieJLiHNieS. Hypoglycemic mechanism of polysaccharide from Cyclocarya paliurus leaves in type 2 diabetic rats by gut microbiota and host metabolism alteration. 2021Jan; 64(1):117–132. https://doi.org/10.1007/s11427-019-1647-6Search in Google Scholar
Liu W, Luo X, Tang J, Mo Q, Zhong H, Zhang H, Feng F. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. Eur J Nutr. 2021 Aug;60(5):2317–2330. https://doi.org/10.1007/s00394-020-02431-wLiuWLuoXTangJMoQZhongHZhangHFengF. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. 2021Aug; 60(5):2317–2330. https://doi.org/10.1007/s00394-020-02431-wSearch in Google Scholar
Madjd A, Taylor MA, Mousavi N, Delavari A, Malekzadeh R, Macdonald IA, Farshchi HR. Comparison of the effect of daily consumption of probiotic compared with low-fat conventional yogurt on weight loss in healthy obese women following an energy-restricted diet: a randomized controlled trial. Am J Clin Nutr. 2016 Feb;103(2):323–329. https://doi.org/10.3945/ajcn.115.120170MadjdATaylorMAMousaviNDelavariAMalekzadehRMacdonaldIAFarshchiHR. Comparison of the effect of daily consumption of probiotic compared with low-fat conventional yogurt on weight loss in healthy obese women following an energy-restricted diet: a randomized controlled trial. 2016Feb; 103(2):323–329. https://doi.org/10.3945/ajcn.115.120170Search in Google Scholar
Magliano DJ, Islam RM, Barr ELM, Gregg EW, Pavkov ME, Harding JL, Tabesh M, Koye DN, Shaw JE. Trends in incidence of total or type 2 diabetes: systematic review. BMJ. 2019 Sep;366:l5003. https://doi.org/10.1136/bmj.l5003MaglianoDJIslamRMBarrELMGreggEWPavkovMEHardingJLTabeshMKoyeDNShawJE. Trends in incidence of total or type 2 diabetes: systematic review. 2019Sep;366:l5003. https://doi.org/10.1136/bmj.l5003Search in Google Scholar
Matheus VA, Monteiro LCS, Oliveira RB, Maschio DA, Collares-Buzato CB. Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. Exp Biol Med. 2017 Jun; 242(12): 1214–1226. https://doi.org/10.1177/1535370217708188MatheusVAMonteiroLCSOliveiraRBMaschioDACollares-BuzatoCB. Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. 2017Jun; 242(12): 1214–1226. https://doi.org/10.1177/1535370217708188Search in Google Scholar
Merino J. Precision nutrition in diabetes: when population-based dietary advice gets personal. Diabetologia. 2022 Nov;65(11):1839–1848. https://doi.org/10.1007/s00125-022-05721-6MerinoJ. Precision nutrition in diabetes: when population-based dietary advice gets personal. 2022Nov; 65(11):1839–1848. https://doi.org/10.1007/s00125-022-05721-6Search in Google Scholar
Naseri K, Saadati S, Ashtary-Larky D, Asbaghi O, Ghaemi F, Pashayee-Khamene F, Yari Z, de Courten B. Probiotics and synbiotics supplementation improve glycemic control parameters in subjects with prediabetes and type 2 diabetes mellitus: A GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Pharmacol Res. 2022 Oct;184:106399. https://doi.org/10.1016/j.phrs.2022.106399NaseriKSaadatiSAshtary-LarkyDAsbaghiOGhaemiFPashayee-KhameneFYariZde CourtenB. Probiotics and synbiotics supplementation improve glycemic control parameters in subjects with prediabetes and type 2 diabetes mellitus: A GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. 2022Oct;184:106399. https://doi.org/10.1016/j.phrs.2022.106399Search in Google Scholar
Nie Q, Hu J, Chen H, Geng F, Nie S. Arabinoxylan ameliorates type 2 diabetes by regulating the gut microbiota and metabolites. Food Chem. 2022 Mar;371:131106. https://doi.org/10.1016/j.foodchem.2021.131106NieQHuJChenHGengFNieS. Arabinoxylan ameliorates type 2 diabetes by regulating the gut microbiota and metabolites. 2022Mar;371:131106. https://doi.org/10.1016/j.foodchem.2021.131106Search in Google Scholar
Okesene-Gafa KA, Moore AE, Jordan V, McCowan L, Crowther CA. Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well-being. Cochrane Database Syst Rev. 2020 Jun;6(6):CD012970. https://doi.org//10.1002/14651858.CD012970.pub2Okesene-GafaKAMooreAEJordanVMcCowanLCrowtherCA. Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well-being. 2020Jun; 6(6):CD012970. https://doi.org//10.1002/14651858.CD012970.pub2Search in Google Scholar
Peng M, Tabashsum Z, Anderson M, Truong A, Houser AK, Padilla J, Akmel A, Bhatti J, Rahaman SO, Biswas D. Effectiveness of probiotics, prebiotics, and prebiotic-like components in common functional foods. Compr Rev Food Sci Food Saf. 2020 Jul;19(4): 1908–1933. https://doi.org/10.1111/1541-4337.12565PengMTabashsumZAndersonMTruongAHouserAKPadillaJAkmelABhattiJRahamanSOBiswasD. Effectiveness of probiotics, prebiotics, and prebiotic-like components in common functional foods. 2020Jul; 19(4): 1908–1933. https://doi.org/10.1111/1541-4337.12565Search in Google Scholar
Pingitore A, Chambers ES, Hill T, Maldonado IR, Liu B, Bewick G, Morrison DJ, Preston T, Wallis GA, Tedford C, et al. The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes Metab. 2017 Feb;19(2):257–265. https://doi.org/10.1111/dom.12811PingitoreAChambersESHillTMaldonadoIRLiuBBewickGMorrisonDJPrestonTWallisGATedfordCThe diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. 2017Feb; 19(2):257–265. https://doi.org/10.1111/dom.12811Search in Google Scholar
Rittiphairoj T, Pongpirul K, Janchot K, Mueller NT, Li T. Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Adv Nutr. 2021 May;12(3):722–734. https://doi.org/10.1093/advances/nmaa133RittiphairojTPongpirulKJanchotKMuellerNTLiT. Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. 2021May; 12(3):722–734. https://doi.org/10.1093/advances/nmaa133Search in Google Scholar
Robertson MD. Prebiotics and type 2 diabetes: targeting the gut microbiota for improved glycaemic control? Pract Diab. 2020 Jul; 37(4):133–137. https://doi.org/10.1002/pdi.2285RobertsonMD. Prebiotics and type 2 diabetes: targeting the gut microbiota for improved glycaemic control?2020Jul; 37(4):133–137. https://doi.org/10.1002/pdi.2285Search in Google Scholar
Rodrigues RR, Gurung M, Li Z, García-Jaramillo M, Greer R, Gaulke C, Bauchinger F, You H, Pederson JW, Vasquez-Perez S, et al. Transkingdom interactions between Lactobacilli and hepatic mitochondria attenuate western diet-induced diabetes. Nat Commun. 2021 Jan;12(1):101. https://doi.org/10.1038/s41467-020-20313-xRodriguesRRGurungMLiZGarcía-JaramilloMGreerRGaulkeCBauchingerFYouHPedersonJWVasquez-PerezSTranskingdom interactions between Lactobacilli and hepatic mitochondria attenuate western diet-induced diabetes. 2021Jan; 12(1):101. https://doi.org/10.1038/s41467-020-20313-xSearch in Google Scholar
Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, Sanders ME, Shamir R, Swann JR, Szajewska H, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):649–667. https://doi.org/10.1038/s41575-021-00440-6SalminenSColladoMCEndoAHillCLebeerSQuigleyEMMSandersMEShamirRSwannJRSzajewskaHThe International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. 2021Sep; 18(9):649–667. https://doi.org/10.1038/s41575-021-00440-6Search in Google Scholar
Schmidt TSB, Raes J, Bork P. The human gut microbiome: from association to modulation. cell. 2018 Mar;172(6):1198–1215. https://doi.org/10.1016/j.cell.2018.02.044SchmidtTSBRaesJBorkP. The human gut microbiome: from association to modulation. 2018Mar; 172(6):1198–1215. https://doi.org/10.1016/j.cell.2018.02.044Search in Google Scholar
Shaukat A, Levitt MD, Taylor BC, MacDonald R, Shamliyan TA, Kane RL, Wilt TJ. Systematic review: effective management strategies for lactose intolerance. Ann Intern Med. 2010 Jun;152(12):797–803. https://doi.org/10.7326/0003-4819-152-12-201006150-00241ShaukatALevittMDTaylorBCMacDonaldRShamliyanTAKaneRLWiltTJ. Systematic review: effective management strategies for lactose intolerance. 2010Jun; 152(12):797–803. https://doi.org/10.7326/0003-4819-152-12-201006150-00241Search in Google Scholar
Song X, Dong H, Zang Z, Wu W, Zhu W, Zhang H, Guan Y. Kudzu resistant starch: an effective regulator of type 2 diabetes mellitus. Oxid Med Cell Longev. 2021 Oct;2021:1–15. https://doi.org/10.1155/2021/4448048SongXDongHZangZWuWZhuWZhangHGuanY. Kudzu resistant starch: an effective regulator of type 2 diabetes mellitus. 2021Oct;2021:1–15. https://doi.org/10.1155/2021/4448048Search in Google Scholar
Sonnenburg JL, Bäckhed F. Diet – microbiota interactions as moderators of human metabolism. Nature. 2016 Jul;535(7610):56–64. https://doi.org/10.1038/nature18846SonnenburgJLBäckhedF. Diet – microbiota interactions as moderators of human metabolism. 2016Jul; 535(7610):56–64. https://doi.org/10.1038/nature18846Search in Google Scholar
Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X, Liu J, Deng Y, Xia J, Chen B, et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med. 2018 Dec;24(12):1919–1929. https://doi.org/10.1038/s41591-018-0222-4SunLXieCWangGWuYWuQWangXLiuJDengYXiaJChenBGut microbiota and intestinal FXR mediate the clinical benefits of metformin. 2018Dec; 24(12):1919–1929. https://doi.org/10.1038/s41591-018-0222-4Search in Google Scholar
Sun L, Yu Z, Ye X, Zou S, Li H, Yu D, Wu H, Chen Y, Dore J, Clément K, et al. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care. 2010 Sep;33(9):1925–1932. https://doi.org/10.2337/dc10-0340SunLYuZYeXZouSLiHYuDWuHChenYDoreJClémentKA marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. 2010Sep; 33(9):1925–1932. https://doi.org/10.2337/dc10-0340Search in Google Scholar
Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, Scott KP, Holscher HD, Azad MB, Delzenne NM, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):687–701. https://doi.org/10.1038/s41575-020-0344-2SwansonKSGibsonGRHutkinsRReimerRAReidGVerbekeKScottKPHolscherHDAzadMBDelzenneNMThe International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. 2020Nov; 17(11):687–701. https://doi.org/10.1038/s41575-020-0344-2Search in Google Scholar
Tao YW, Gu YL, Mao XQ, Zhang L, Pei YF. Effects of probiotics on type II diabetes mellitus: a meta-analysis. J Transl Med. 2020 Dec; 18(1):30. https://doi.org/10.1186/s12967-020-02213-2TaoYWGuYLMaoXQZhangLPeiYF. Effects of probiotics on type II diabetes mellitus: a meta-analysis. 2020Dec; 18(1):30. https://doi.org/10.1186/s12967-020-02213-2Search in Google Scholar
Tonucci LB, Olbrich dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS. Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. Clin Nutr. 2017 Feb;36(1):85–92. https://doi.org/10.1016/j.clnu.2015.11.011TonucciLBOlbrich dos SantosKMLicursi de OliveiraLRocha RibeiroSMDuarte MartinoHS. Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. 2017Feb; 36(1):85–92. https://doi.org/10.1016/j.clnu.2015.11.011Search in Google Scholar
Waddell IS, Orfila C. Dietary fiber in the prevention of obesity and obesity-related chronic diseases: from epidemiological evidence to potential molecular mechanisms. Crit Rev Food Sci Nutr. 2022 Apr; 1–16. https://doi.org/10.1080/10408398.2022.2061909WaddellISOrfilaC. Dietary fiber in the prevention of obesity and obesity-related chronic diseases: from epidemiological evidence to potential molecular mechanisms. 2022Apr; 1–16. https://doi.org/10.1080/10408398.2022.2061909Search in Google Scholar
Wan MLY, Forsythe SJ, El-Nezami H. Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges. Crit Rev Food Sci Nutr. 2019 Nov;59(20):3320–3333. https://doi.org/10.1080/10408398.2018.1490885WanMLYForsytheSJEl-NezamiH. Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges. 2019Nov; 59(20):3320–3333. https://doi.org/10.1080/10408398.2018.1490885Search in Google Scholar
Wang C, Wei S, Liu B, Wang F, Lu Z, Jin M, Wang Y. Maternal consumption of a fermented diet protects offspring against intestinal inflammation by regulating the gut microbiota. Gut Microbes. 2022 Dec;14(1):2057779. https://doi.org/10.1080/19490976.2022.2057779WangCWeiSLiuBWangFLuZJinMWangY. Maternal consumption of a fermented diet protects offspring against intestinal inflammation by regulating the gut microbiota. 2022Dec; 14(1):2057779. https://doi.org/10.1080/19490976.2022.2057779Search in Google Scholar
Wang Y, Dilidaxi D, Wu Y, Sailike J, Sun X, Nabi XH. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomed Pharmacother. 2020 May;125:109914. https://doi.org/10.1016/j.biopha.2020.109914WangYDilidaxiDWuYSailikeJSunXNabiXH. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. 2020May;125:109914. https://doi.org/10.1016/j.biopha.2020.109914Search in Google Scholar
Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011 Oct;334(6052):105–108. https://doi.org/10.1126/science.1208344WuGDChenJHoffmannCBittingerKChenYYKeilbaughSABewtraMKnightsDWaltersWAKnightRLinking long-term dietary patterns with gut microbial enterotypes. 2011Oct; 334(6052):105–108. https://doi.org/10.1126/science.1208344Search in Google Scholar
Yan F, Li N, Yue Y, Wang C, Zhao L, Evivie SE, Li B, Huo G. Screening for potential novel probiotics with dipeptidyl peptidase IV-inhibiting activity for type 2 diabetes attenuation in vitro and in vivo. Front Microbiol. 2020 Jan;10:2855. https://doi.org/10.3389/fmicb.2019.02855YanFLiNYueYWangCZhaoLEvivieSELiBHuoG. Screening for potential novel probiotics with dipeptidyl peptidase IV-inhibiting activity for type 2 diabetes attenuation in vitro and in vivo. 2020Jan;10:2855. https://doi.org/10.3389/fmicb.2019.02855Search in Google Scholar
Ye J, Lv L, Wu W, Li Y, Shi D, Fang D, Guo F, Jiang H, Yan R, Ye W, et al. Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front Microbiol. 2018 Aug;9:1967. https://doi.org/10.3389/fmicb.2018.01967YeJLvLWuWLiYShiDFangDGuoFJiangHYanRYeWButyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. 2018Aug;9:1967. https://doi.org/10.3389/fmicb.2018.01967Search in Google Scholar
Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X, Ma J, Gu X, Xue Y, Huang S, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020 Oct;11(1):5015. https://doi.org/10.1038/s41467-020-18414-8ZhangYGuYRenHWangSZhongHZhaoXMaJGuXXueYHuangSGut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). 2020Oct; 11(1):5015. https://doi.org/10.1038/s41467-020-18414-8Search in Google Scholar
Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018 Mar;359(6380):1151–1156. https://doi.org/10.1126/science.aao5774ZhaoLZhangFDingXWuGLamYYWangXFuHXueXLuCMaJGut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. 2018Mar; 359(6380):1151–1156. https://doi.org/10.1126/science.aao5774Search in Google Scholar
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88–98. https://doi.org/10.1038/nrendo.2017.151ZhengYLeySHHuFB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. 2018Feb; 14(2):88–98. https://doi.org/10.1038/nrendo.2017.151Search in Google Scholar
Zhong H, Abdullah, Zhao M, Tang J, Deng L, Feng F. Probiotics-fermented blueberry juices as potential antidiabetic product: anti-oxidant, antimicrobial and antidiabetic potentials. J Sci Food Agric. 2021 Aug;101(10):4420–4427. https://doi.org/10.1002/jsfa.11083ZhongHAbdullahZhaoMTangJDengLFengF. Probiotics-fermented blueberry juices as potential antidiabetic product: anti-oxidant, antimicrobial and antidiabetic potentials. 2021Aug; 101(10):4420–4427. https://doi.org/10.1002/jsfa.11083Search in Google Scholar